ACE2 and COVID-19: We find that HCMV infection of a number of biologically relevant cell types upregulates the SARS-CoV-2 entry receptor, angiotensin converting enzyme 2 (ACE2), and significantly enhances SARS-CoV-2 infection, which could have important implications for the pathogenesis and treatment of COVID-19.